Central Nervous System Disorders is under clinical development by Neuroplast and currently in Phase I for Amyotrophic Lateral Sclerosis.

Acetylcysteine zidrimer is under clinical development by Orpheris and currently in Phase II for Amyotrophic Lateral Sclerosis.

The 4th annual Rally 4 Nally polar plunge took place on Saturday to raise awareness and donations for ALS. Rally 4 Nally, is ...

High levels of cholesterol are a risk factor for atherosclerosis and cardiovascular diseases, which can lead to ...

Amyotrophic lateral sclerosis (ALS) is a serious and usually fatal neurodegenerative disorder in which motor neurons deteriorate and die. | Genetics And Genomics ...

After being diagnosed with ALS in 2022, Brooke Eby could have turned inward. Instead, she opened up — and found a fan base ...

StockNews.com started coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a report published on Friday morning. The firm issued a sell rating on the biopharmaceutical ...

Here's a look at the Cincinnati TV journalists who left and joined their stations in 2024, plus other major events.

The creatinine-to-cystatin C ratio may indicate the risk of developing amyotrophic lateral sclerosis, a large-scale database ...

Chinese startup NeuroXess' new BCI can decipher the complex Chinese language in brain, operate a robotic arm and interact with AI.

After raising AU$16.75 million (US$10.4 million) in a series A round, Celosia Therapeutics Pty Ltd. is heading toward the clinic with its novel gene therapy that targets TDP-43, a protein directly ...